Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
Conventional disease-modifying antirheumatic drugs such as methotrexate are the mainstay of treatment for rheumatoid arthritis. More recently, biologic agents such as etanercept, infliximab and adalimumab, whi...
Arthritis Research & Therapy 2009 11(Suppl 1):S1
Published on: 6 April 2009